Continuation of Antidumping Duty Order: Aspirin From Turkey

DEPARTMENT OF COMMERCE

International Trade Administration

[A-489-602]

Continuation of Antidumping Duty Order: Aspirin From Turkey

AGENCY: Import Administration, International Trade Administration,

Department of Commerce.

ACTION: Notice of Continuation of Antidumping Duty Order: Aspirin from

Turkey.

-----------------------------------------------------------------------

SUMMARY: On July 6, 1999, the Department of Commerce (``the

Department''), pursuant to sections 751(c) and 752 of the Tariff Act

from 1930, as amended (``the Act''), determined that revocation of the

antidumping duty order on aspirin from Turkey would be likely to lead

to continuation or recurrence of dumping (64 FR 36328 (July 6, 1999)).

On August 4, 1999, the International Trade Commission (``the

Commission''), pursuant to section 751(c) of the Act, determined that

revocation of the antidumping duty order on aspirin from Turkey would

likely to lead to continuation or recurrence of material injury to an

industry in the United States within a reasonably foreseeable time (64

FR 42414 (August 4, 1999)). Therefore, pursuant to 19 CFR

351.218(f)(4), the Department is publishing notice of the continuation

of the antidumping duty order on aspirin from Turkey.

FOR FURTHER INFORMATION CONTACT: Scott E. Smith or Melissa G. Skinner,

Office of Policy for Import Administration, International Trade

Administration, U.S. Department of Commerce, 14th and Constitution

Ave., NW, Washington, DC 20230; telephone (202) 482-6397 or (202) 482-

1560, respectively.

EFFECTIVE DATE: August 20, 1999.

Background

On March 1, 1999, the Department initiated, and the Commission

instituted, a sunset review (64 FR 9970 and 64 FR 10012, respectively)

of the antidumping duty order on aspirin from Turkey pursuant to

section 751(c) of the Act. As a result of this review, the Department

found that revocation of the antidumping duty order would likely lead

to continuation or recurrence of dumping and notified the Commission of

the magnitude of the margin likely to prevail were the order to be

revoked. (See Final Results of Expedited Sunset Review: Aspirin from

Turkey, 64 FR 36328 (July 6, 1999)).

On August 4, 1999, the Commission determined, pursuant to section

751(c) of the Act, that revocation of the antidumping duty order on

aspirin from Turkey would likely lead to continuation or recurrence of

material injury to an industry in the United States within a reasonably

foreseeable time. (See Aspirin from Turkey, 64 FR 42414 (August 4,

1999), and USITC Pub. 3215, Inv. No. 731-TA-364 (Review) (July 1999)).

Scope

The merchandise covered by this antidumping duty order is

acetylsalicylic acid (aspirin) from Turkey containing no additives,

other than inactive substances (such as starch, lactose, cellulose, or

coloring materials), and/or active substances in concentrations less

than that specified for particular nonprescription drug combinations of

aspirin and active substances as published in the Handbook of

Nonprescription Drugs, eighth edition, American Pharmaceutical

Association, and is not in tablet, capsule or similar forms for direct

human consumption. This product is classified under the Harmonized

Tariff Schedule (HTS) subheading 2918.22.10. The HTS number is provided

for convenience and customs purposes. The written description remains

dispositive.

Determination

As a result of the determinations by the Department and the

Commission that revocation of this antidumping duty order would be

likely to lead to continuation or recurrence of dumping and material

injury to an industry in the United States, pursuant to section

751(d)(2) of the Act, the Department hereby orders the continuation of

the antidumping duty order on aspirin from Turkey. The Department will

instruct the U.S. Customs Service to continue to collect antidumping

duty deposits at the rate in effect at the time of entry for all

imports of subject merchandise. Pursuant to section 751(c)(6)(A)(iii)

of the Act, any subsequent five-year review of this order will be

initiated not later than the fifth anniversary of the effective date of

continuation of this order.

The effective date of continuation of a finding, order, or

suspension agreement will be the date of publication in the Federal

Register of the Notice of Continuation. As provided in 19 CFR

351.218(f)(4), the Department will issue its determination to continue

a finding, order, or suspended investigation not later than seven days

after the date of publication in the Federal Register of the

Commission's determination concluding the sunset review and immediately

thereafter will publish its notice of continuation in the Federal

Register. As a result, pursuant to section 751(c)(2) and 751(c)(6)(A)

of the Act, the Department intends to initiate the next five-year

review of this order not later than thirty (30) days before the fifth

anniversary of the effective date of this notice.

Dated: August 13, 1999.

Robert S. LaRussa,

Assistant Secretary for Import Administration.

[FR Doc. 99-21714 Filed 8-19-99; 8:45 am]

BILLING CODE 3510-DS-P